The Cancer of the Pancreas Screening-5 (CAPS5) Study

Conditions

Pancreas | Prevention

What is the purpose of this trial?

The purpose of the study is to evaluate pancreatic fluid mutations and circulating pancreatic epithelial cells as accurate markers of neoplasia by comparing their prevalence in cases with sporadic pancreatic neoplasia to healthy and disease controls; to compare the prevalence of pancreatic fluid mutations and circulating pancreatic epithelial cells among a prospective cohort of individuals with sporadic pancreatic cysts undergoing pancreatic surveillance.

  • Trial with
    American Association for Cancer Research
  • Start Date
    05/11/2015
  • End Date
    10/30/2021
Trial Image

For more information about this study, contact:

James Farrell

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

  • Last Updated
    06/22/2018
  • Study HIC
    #1408014448